Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021

INTRODUCTION: Biomarker testing is increasingly crucial for patients with early-stage non-small cell lung cancer (eNSCLC). We explored biomarker test utilization and subsequent treatment in eNSCLC patients in the real-world setting. METHODS: Using COTA’s oncology database, this retrospective observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jessie T., Jin, Yue, Lo, Ernest, Chen, Yilin, Hanlon Newell, Amy E., Kong, Ying, Inge, Landon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447355/
https://www.ncbi.nlm.nih.gov/pubmed/37330972
http://dx.doi.org/10.1007/s40487-023-00234-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447355/
https://www.ncbi.nlm.nih.gov/pubmed/37330972
http://dx.doi.org/10.1007/s40487-023-00234-7

Ejemplares similares